Showing 1 - 4 results of 4 for search 'Ravi K. Goyal', query time: 0.03s Refine Results
  1. 1
    Treatment patterns, adverse events, and economic burden in a privately insured population of patients with chronic lymphocytic leukemia in the United States

    Treatment patterns, adverse events, and economic burden in a privately insured population of patients with chronic lymphocytic leukemia in the United States by Shaum M. Kabadi, Ravi K. Goyal, Saurabh P. Nagar, James A. Kaye, Keith L. Davis

    Published 2019-07-01
    Get full text
    Article
  2. 2
    Overall survival, adverse events, and economic burden in patients with chronic lymphocytic leukemia receiving systemic therapy: Real‐world evidence from the medicare population

    Overall survival, adverse events, and economic burden in patients with chronic lymphocytic leukemia receiving systemic therapy: Real‐world evidence from the medicare population by Ravi K. Goyal, Saurabh P. Nagar, Shaum M. Kabadi, Hannah Le, Keith L. Davis, James A. Kaye

    Published 2021-04-01
    Get full text
    Article
  3. 3
    Real‐world treatment patterns, adverse events and clinical outcomes in patients with chronic lymphocytic leukaemia treated with ibrutinib in the UK

    Real‐world treatment patterns, adverse events and clinical outcomes in patients with chronic lymphocytic leukaemia treated with ibrutinib in the UK by Peter Hillmen, Jing Xie, Alan S. M. Yong, Catherine Waweru, Thuy Anh Sorof, Ravi K. Goyal, Keith L. Davis

    Published 2021-05-01
    Get full text
    Article
  4. 4
    P924: TREATMENT PATTERNS OF TRIPLE-CLASS REFRACTORY (TCR) MULTIPLE MYELOMA (MM) ACROSS THE UNITED STATES (US), CANADA, AND WESTERN EUROPE: A REAL-WORLD OBSERVATIONAL CHART REVIEW STUDY

    P924: TREATMENT PATTERNS OF TRIPLE-CLASS REFRACTORY (TCR) MULTIPLE MYELOMA (MM) ACROSS THE UNITED STATES (US), CANADA, AND WESTERN EUROPE: A REAL-WORLD OBSERVATIONAL CHART REVIEW S... by Ravi K Goyal, Gaelle Frugier, Julien Rombi, Lizzi Esterberg, Keith Davis, Patrick Hlavacek, Jinma Ren, Alex Schepart, Didem Aydin, Marco Dibonaventura

    Published 2023-08-01
    Get full text
    Article

Search Tools: